Role of Stress Cardiac MRI in Predicting Adverse Clinical Events in Patients With Known or Suspected Ischemic Heart Disease
This trial is active, not recruiting.
|Condition||coronary artery disease|
|Sponsor||Brigham and Women's Hospital|
|Start date||January 2012|
|End date||January 2016|
|Trial size||400 participants|
|Trial identifier||NCT01821924, 2011P000643|
The investigators plan to use retrospective data to assess heart function and structure abnormalities through the use of an approved vasodilating agent for stress cardiac MRI tests. The investigators are interested in how these MRI findings relate to long-term prognosis in people who are at risk for cardiac disease.
All-cause mortality, MI, heart failure hospitalization or documentation of an LV ejection fraction < 0.40 after index CMR at a follow-up.
time frame: 5 years
Male or female participants at least 21 years old.
Inclusion Criteria: - Age >/= 21 years old - No contraindications for cardiac MRI (by renal function or metallic hazards)
Call for more information